Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Хронический эндометрит как исход инфекционного воспалительного заболевания матки
Хронический эндометрит как исход инфекционного воспалительного заболевания матки
Кузнецова И.В., Землина Н.С., Рашидов Т.Н. Хронический эндометрит как исход инфекционного воспалительного заболевания матки. Гинекология. 2016; 18 (2): 44–50.
18 (№): 44–50.
________________________________________________
18 (№): 44–50.
Материалы доступны только для специалистов сферы здравоохранения. Авторизуйтесь или зарегистрируйтесь.
Аннотация
Хронический эндометрит – одна из актуальных проблем современной гинекологии. Трудности верификации, отсутствие единства в понимании природы воспалительного поражения эндометрия, малосимптомная картина при множественных негативных исходах для репродукции – все это определяет интерес к патогенезу, диагностике и лечению хронического эндометрита. Лечение эндометрита, как формы воспалительного заболевания органов малого таза, лежит в плоскости применения антибиотикотерапии. Однако формирование хронического воспаления связано не столько с вирулентностью микроорганизма, сколько с особенностями иммунной реакции макроорганизма и локальным иммунитетом эндометрия. Это обосновывает использование в комплексной терапии иммуномодулирующих средств и препаратов, обладающих протеолитическим действием, направленным на предотвращение фиброза и склероза тканей. Одним из таких лекарственных средств является бовгиалуронидаза азоксимер (препарат Лонгидаза®).
Ключевые слова: хронический эндометрит, воспалительные заболевания органов малого таза, внутриматочные сращения, воспаление, фиброз, антибиотикотерапия, иммуномодуляция, бовгиалуронидаза азоксимер.
Key words: chronic endometritis, inflammatory diseases of the pelvic organs, intrauterine adhesions, inflammation, fibrosis, antibiotic therapy, immunomodulation, bovhyaluronidase azoximer.
Ключевые слова: хронический эндометрит, воспалительные заболевания органов малого таза, внутриматочные сращения, воспаление, фиброз, антибиотикотерапия, иммуномодуляция, бовгиалуронидаза азоксимер.
________________________________________________
Key words: chronic endometritis, inflammatory diseases of the pelvic organs, intrauterine adhesions, inflammation, fibrosis, antibiotic therapy, immunomodulation, bovhyaluronidase azoximer.
Полный текст
Список литературы
1. Унанян А.Л., Коссович Ю.М. Хронический эндометрит: этиопатогенез, диагностика, клиника и лечение. Роль антифиброзирующей терапии. Лечащий врач. 2012; 11: 35–40. / Unanian A.L., Kossovich Iu.M. Khronicheskii endometrit: etiopatogenez, diagnostika, klinika i lechenie. Rol' antifibroziruiushchei terapii. Lechashchii vrach. 2012; 11: 35–40. [in Russian]
2. Шуршалина А.В. Оптимизация тактики ведения пациенток с воспалительными заболеваниями органов малого таза. Гинекология. 2012; 14 (2). / Shurshalina A.V. Optimizatsiia taktiki vedeniia patsientok s vospalitel'nymi zabolevaniiami organov malogo taza. Ginekology. 2012; 14 (2). [in Russian]
3. Мотовилова Т.М., Качалина Т.С., Аникина Т.А. Альтернативный подход к лечению больных с хроническим неспецифическим эндометритом. РМЖ. Мать и дитя. 2013; 14: 751–6. / Motovilova T.M., Kachalina T.S., Anikina T.A. Al'ternativnyi podkhod k lecheniiu bol'nykh s khronicheskim nespetsificheskim endometritom. RMZh. Mat' i ditia. 2013; 14: 751–6. [in Russian]
4. Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Cur Opin Infect Dis 2008; 21 (1): 65–9.
5. Kumbak B, Erden HF, Tosun S et al. Outcome of assisted reproduction treatmentin patients with endometrial thickness less then 7 mm. Reprod Biomed Online 2009; 18 (1): 79–84.
6. Глухова Е.В., Шаховская И.Н. Микробиологическая характеристика биотопов репродуктивного тракта при эндометрите. Тольяттинский мед. консилиум. 2011; 1–2: 38–44. / Glukhova E.V., Shakhovskaia I.N. Mikrobiologicheskaia kharakteristika biotopov reproduktivnogo trakta pri endometrite. Tol'iattinskii med. konsilium. 2011; 1–2: 38–44. [in Russian]
7. Бухарин О.В., Черкасов С.В., Сгибнев А.В. и др. Характеристика микроэкологических нарушений при эндометрите. Журн. микробиологии, эпидемиологии и иммунобиологии. 2009; 4: 93–6. / Bukharin O.V., Cherkasov S.V., Sgibnev A.V. i dr. Kharakteristika mikroekologicheskikh narushenii pri endometrite. Zhurn. mikrobiologii, epidemiologii i immunobiologii. 2009; 4: 93–6. [in Russian]
8. Шуршалина А.В. Хронический эндометрит: современные подходы к терапии.Consilium Medicum. 2009; 11 (6): 36–8. / Shurshalina A.V. Khronicheskii endometrit: sovremennye podkhody k terapii.Consilium Medicum. 2009; 11 (6): 36–8. [in Russian]
9. Aslim B, Kilic E. Some probiotic properties of vaginal lactobacilli isolated from healthy women. Jpn J Infect Dis 2006; 59 (4): 249–53.
10. Dimitonova SP, Danova ST, Serkedjieva JP et al. Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women. Anaerobe 2007; 13 (5–6): 178–84.
11. Garg KB, Ganguli I, Das R et al. Spectrum of Lactobacillus species present in healthy vagina of Indian women. Indian J Med Res 2009; 129 (6): 652–7.
12. Martin R, Suarez JE. Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol 2010; 76 (2): 400–5.
13. Tamrakar R, Yamada T, Furuta I et al. Association between Lactobacillus species and bacterilvaginosis – related bacteri, and bacterial vaginosis scores in pregnant Japanese women. ВМС Infect Dis 2007; 7: 128.
14. Aagaard K, Petrosino J, Keitel W et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. J FASEB J 2013; 27 (3): 1012–22.
15. Тапильская Н.И., Карпеев С.А., Кузнецова И.В. Хронический эндометрит – субклиническое воспалительное заболевание органов малого таза. Гинекология. 2014; 1: 104–9. / Tapil'skaia N.I., Karpeev S.A., Kuznetsova I.V. Khronicheskii endometrit – subklinicheskoe vospalitel'noe zabolevanie organov malogo taza. Ginekology. 2014; 1: 104–9. [in Russian]
16. Amsler L, Malouli D, De Filippi V. The inflammasome as a target of modulation by DNA viruses. Future Virol Author manuscript; available in PMC Jun 18, 2014.
17. Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J Reprod Immunol 2008; 77: 7–13.
18. Hirata T, Osuga Y, Hamasakia K et al. Expression of toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. J Reprod Immunol 2007; 74 (1–2): 53–60.
19. Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction 2008; 135: 739–49.
20. Le Bouteiller P, Tabiasco J. Killers become builders during pregnancy. Nat Med 2006; 12: 991–2.
21. Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13: 24–8.
22. Tuckerman E, Larid SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 2007; 8: 2208–13.
23. Серебренникова С.Н., Семинский И.Ж. Роль цитокинов в воспалительном процессе (сообщение 2). Сиб. мед. журн. 2008; 83 (8): 5–9. / Serebrennikova S.N., Seminskii I.Zh. Rol' tsitokinov v vospalitel'nom protsesse (soobshchenie 2). Sib. med. zhurn. 2008; 83 (8): 5–9. [in Russian]
24. Smith M, Hagerty KA, Skipper B et al. Chronic endometritis: a combined histopathologic and clinical review of cases from 2002 to 2007. Int J Gynecol Pathol 2010; 29 (1): 44–50.
25. Pitsos M, Skurnick J, Heller D. Association of pathologic diagnoses with clinical findings in chronic endometritis. J Reprod Med 2009; 54 (6): 373–7.
26. Killick SR. Ultrasound and the receptivity of the endometrium. Reprod Biomed Online 2007; 15 (1): 63–7.
27. Caserta L, Labriola D, Torella M et al. The use of transvaginal ultrasound following voluntary interruption f pregnancy to reduce complications due to incomplete curettage. Minerva Ginecol 2008; 60 (1): 7–13.
28. Merce LT, Barco MJ, Bau S et al. Are endometrial parameters by threedimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril 2008; 89 (1): 111–7.
29. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Obstet Gynecol Int 2009; 397079.
30. Озерская И.А., Агеева М.И., Заева В.В. Комплексное ультразвуковое исследование матки у женщин после неудачных попыток экстракорпорального оплодотворения. Ультразвук. функц. диагностика. 2006; 6: 41–50. / Ozerskaia I.A., Ageeva M.I., Zaeva V.V. Kompleksnoe ul'trazvukovoe issledovanie matki u zhenshchin posle neudachnykh popytok ekstrakorporal'nogo oplodotvoreniia. Ul'trazvuk. funkts. diagnostika. 2006; 6: 41–50. [in Russian]
31. Kasius A, Smit JG, Torrance HL et al. Endometrial thickness and pregnancy rates after IVF: a systemstic review and metaanalysis. Hum Reprod Update 2014; 20 (4): 530–41.
32. Wang L, Qiao J, Li R et al. Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF – ET cycles. Reprod Bio lEndocrinol 2010; 8: 122.
33. Germeyer A, von Wolff M, Jauckus J et al. Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures – a pilot study. Reprod Biol Endocrinol 2010; 21 (21): 67.
34. Ng EH, Chan CC, Tang OS et al. Factors affecting endometrial and subendometrial blood flow measured by three – dimensional power Doppler ultrasound during IVF treatment. Hum Repord 2006; 21 (4): 1062–9.
35. Ng EN, Chan CC, Tang OS et al. The role of endometrial blood flow measured by three – dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment. Eur J Obsted Gynecol Repord Biol 2007; 135 (1): 8–16.
36. McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 2006; 59 (8): 801–12.
37. Adegboyega PA, Pei Y, McLarty J. Relationship between eosinofhils and chronic endometritis. Hum Pathol 2010; 41 (1): 33–7.
38. Gilmore H, Fleischhacker D, Hecht JL. Diagnosis of chronic endometritis in biopsies with stromal breakdown. Hum Pathol 2007; 38 (4): 581–4.
39. Giordano G. Value of immunohistochemistry in uterine pathology: common and rare diagnostic dilemmas. Pathol Res Pract 2009; 205 (10): 663–76.
40. Vicetti Miguel RD, Chivukula M, Krishnamurti U et al. Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research. Pathol Res Pract 2011; 207 (11): 680–5.
41. Toth B, Würfel W, Bohlmann MK et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).GeburtshilfeFrauenheilkd 2015; 75 (11): 1117–29.
42. Серов В.Н., Коган Е.А., Силантьева В.С. и др. Комплексное лечение хронического эндометрита: клинико-морфологическое обоснование использования физиотерапии. Акушерство и гинекология. 2006; 3: 46–50. / Serov V.N., Kogan E.A., Silant'eva V.S. i dr. Kompleksnoe lechenie khronicheskogo endometrita: kliniko-morfologicheskoe obosnovanie ispol'zovaniia fizioterapii. Akusherstvo i ginekologiia. 2006; 3: 46–50. [in Russian]
43. Серов В.Н. Физические методы предгестационной подготовки эндометрия: синдромально-патогенетический подход. Вопр. курортологии, физиотерапии и лечебной физкультуры. 2007; 2: 21–6. / Serov V.N. Fizicheskie metody predgestatsionnoi podgotovki endometriia: sindromal'no-patogeneticheskii podkhod. Vopr. kurortologii, fizioterapii i lechebnoi fizkul'tury. 2007; 2: 21–6. [in Russian]
44. Гомберг М.А. Ведение пациенток с воспалительными заболеваниями органов малого таза: обзор Европейского руководства Международного союза по борьбе с инфекциями, передаваемыми половым путем (IUSTI). Гинекология. 2013; 15 (6): 46–9. / Gomberg M.A. Vedenie patsientok s vospalitel'nymi zabolevaniiami organov malogo taza: obzor Evropeiskogo rukovodstva Mezhdunarodnogo soiuza po bor'be s infektsiiami, peredavaemymi polovym putem (IUSTI). Ginekology. 2013; 15 (6): 46–9. [in Russian]
45. Тапильская Н.И. Применение вильпрофена у пациенток с бесплодием и привычным невынашиванием беременности на этапе предгравидарной подготовки. Трудный пациент. 2010; 1–2: 27–30. / Tapil'skaia N.I. Primenenie vil'profena u patsientok s besplodiem i privychnym nevynashivaniem beremennosti na etape predgravidarnoi podgotovki. Trudnyi patsient. 2010; 1–2: 27–30. [in Russian]
46. Сухих Г.Т., Шуршалина А.В. Хронический эндометрит: руководство. М.: ГЭОТАР–Медиа, 2013. / Sukhikh G.T., Shurshalina A.V. Khronicheskii endometrit: rukovodstvo. M.: GEOTAR–Media, 2013. [in Russian]
47. Алимова О.А. Клинико-морфологическая характеристика хронического эндометрита различной этиологии. Автореф. дис. … канд. мед. наук. Челябинск, 2011. / Alimova O.A. Kliniko-morfologicheskaia kharakteristika khronicheskogo endometrita razlichnoi etiologii. Avtoref. dis. … kand. med. nauk. Cheliabinsk, 2011. [in Russian]
48. Боровкова Л.В., Колобова С.О. Влияние препарата иммуновит на состояние клеточного иммунитета при невынашивании беременности инфекционного генеза. Медицинский альманах. 2010; 2: 174–6. / Borovkova L.V., Kolobova S.O. Vliianie preparata immunovit na sostoianie kletochnogo immuniteta pri nevynashivanii beremennosti infektsionnogo geneza. Meditsinskii al'manakh. 2010; 2: 174–6. [in Russian]
49. Дубницкая Л.В. Хронический эндометрит: возможности диагностики и лечения.Consilium Medicum. 2007; 9 (6): 25–8. / Dubnitskaia L.V. Khronicheskii endometrit: vozmozhnosti diagnostiki i lecheniia.Consilium Medicum. 2007; 9 (6): 25–8. [in Russian]
50. Назаренко Т.А., Дубницкая Л.В. Применение препарата Лонгидаза в комплексной терапии патологических изменений эндометрия. Акушерство и гинекология. 2007; 5: 95–8. / Nazarenko T.A., Dubnitskaia L.V. Primenenie preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Akusherstvo i ginekologiia. 2007; 5: 95–8. [in Russian]
51. Назаренко Т.А., Дубницкая Л.В. Возможности применения препарата Лонгидаза в комплексной терапии патологических изменений эндометрия. Рус. мед. журн. 2008; 9: 24–9. / Nazarenko T.A., Dubnitskaia L.V. Vozmozhnosti primeneniia preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Rus. med. zhurn. 2008; 9: 24–9. [in Russian]
52. Петрович Е.А., Колесов А.А., Манухин И.Б. Безопасность и эффективность препарата «Лонгидаза» 3000 МЕ при лечении больных, страдающих спаечным процессом в малом тазу. Иммунология. 2006; 2: 124–6. / Petrovich E.A., Kolesov A.A., Manukhin I.B. Bezopasnost' i effektivnost' preparata «Longidaza» 3000 ME pri lechenii bol'nykh, stradaiushchikh spaechnym protsessom v malom tazu. Immunologiia. 2006; 2: 124–6. [in Russian]
53. Трошина Н.А., Долгушин И.И., Долгушина В.Ф. и др. Микробиологическая эффективность препарата на основе гиалуронидазы у пациенток с хроническим эндометритом и миомой матки. Гинекология. 2015; 17 (6): 42–5. / Troshina N.A., Dolgushin I.I., Dolgushina V.F. i dr. Mikrobiologicheskaia effektivnost' preparata na osnove gialuronidazy u patsientok s khronicheskim endometritom i miomoi matki. Ginekology. 2015; 17 (6): 42–5. [in Russian]
54. Царькова М.А., Семенцова Н.А. Новый подход к комплексной терапии патологии эндометрия. Гинекология. 2015; 16 (5): 110–3. / Tsar'kova M.A., Sementsova N.A. Novyi podkhod k kompleksnoi terapii patologii endometriia. Ginekology. 2015; 16 (5): 110–3. [in Russian]
2. Shurshalina A.V. Optimizatsiia taktiki vedeniia patsientok s vospalitel'nymi zabolevaniiami organov malogo taza. Ginekology. 2012; 14 (2). [in Russian]
3. Motovilova T.M., Kachalina T.S., Anikina T.A. Al'ternativnyi podkhod k lecheniiu bol'nykh s khronicheskim nespetsificheskim endometritom. RMZh. Mat' i ditia. 2013; 14: 751–6. [in Russian]
4. Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Cur Opin Infect Dis 2008; 21 (1): 65–9.
5. Kumbak B, Erden HF, Tosun S et al. Outcome of assisted reproduction treatmentin patients with endometrial thickness less then 7 mm. Reprod Biomed Online 2009; 18 (1): 79–84.
6. Glukhova E.V., Shakhovskaia I.N. Mikrobiologicheskaia kharakteristika biotopov reproduktivnogo trakta pri endometrite. Tol'iattinskii med. konsilium. 2011; 1–2: 38–44. [in Russian]
7. Bukharin O.V., Cherkasov S.V., Sgibnev A.V. i dr. Kharakteristika mikroekologicheskikh narushenii pri endometrite. Zhurn. mikrobiologii, epidemiologii i immunobiologii. 2009; 4: 93–6. [in Russian]
8. Shurshalina A.V. Khronicheskii endometrit: sovremennye podkhody k terapii.Consilium Medicum. 2009; 11 (6): 36–8. [in Russian]
9. Aslim B, Kilic E. Some probiotic properties of vaginal lactobacilli isolated from healthy women. Jpn J Infect Dis 2006; 59 (4): 249–53.
10. Dimitonova SP, Danova ST, Serkedjieva JP et al. Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women. Anaerobe 2007; 13 (5–6): 178–84.
11. Garg KB, Ganguli I, Das R et al. Spectrum of Lactobacillus species present in healthy vagina of Indian women. Indian J Med Res 2009; 129 (6): 652–7.
12. Martin R, Suarez JE. Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol 2010; 76 (2): 400–5.
13. Tamrakar R, Yamada T, Furuta I et al. Association between Lactobacillus species and bacterilvaginosis – related bacteri, and bacterial vaginosis scores in pregnant Japanese women. ВМС Infect Dis 2007; 7: 128.
14. Aagaard K, Petrosino J, Keitel W et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. J FASEB J 2013; 27 (3): 1012–22.
15. Tapil'skaia N.I., Karpeev S.A., Kuznetsova I.V. Khronicheskii endometrit – subklinicheskoe vospalitel'noe zabolevanie organov malogo taza. Ginekology. 2014; 1: 104–9. [in Russian]
16. Amsler L, Malouli D, De Filippi V. The inflammasome as a target of modulation by DNA viruses. Future Virol Author manuscript; available in PMC Jun 18, 2014.
17. Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J Reprod Immunol 2008; 77: 7–13.
18. Hirata T, Osuga Y, Hamasakia K et al. Expression of toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. J Reprod Immunol 2007; 74 (1–2): 53–60.
19. Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction 2008; 135: 739–49.
20. Le Bouteiller P, Tabiasco J. Killers become builders during pregnancy. Nat Med 2006; 12: 991–2.
21. Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13: 24–8.
22. Tuckerman E, Larid SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 2007; 8: 2208–13.
23. Serebrennikova S.N., Seminskii I.Zh. Rol' tsitokinov v vospalitel'nom protsesse (soobshchenie 2). Sib. med. zhurn. 2008; 83 (8): 5–9. [in Russian]
24. Smith M, Hagerty KA, Skipper B et al. Chronic endometritis: a combined histopathologic and clinical review of cases from 2002 to 2007. Int J Gynecol Pathol 2010; 29 (1): 44–50.
25. Pitsos M, Skurnick J, Heller D. Association of pathologic diagnoses with clinical findings in chronic endometritis. J Reprod Med 2009; 54 (6): 373–7.
26. Killick SR. Ultrasound and the receptivity of the endometrium. Reprod Biomed Online 2007; 15 (1): 63–7.
27. Caserta L, Labriola D, Torella M et al. The use of transvaginal ultrasound following voluntary interruption f pregnancy to reduce complications due to incomplete curettage. Minerva Ginecol 2008; 60 (1): 7–13.
28. Merce LT, Barco MJ, Bau S et al. Are endometrial parameters by threedimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril 2008; 89 (1): 111–7.
29. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Obstet Gynecol Int 2009; 397079.
30. Ozerskaia I.A., Ageeva M.I., Zaeva V.V. Kompleksnoe ul'trazvukovoe issledovanie matki u zhenshchin posle neudachnykh popytok ekstrakorporal'nogo oplodotvoreniia. Ul'trazvuk. funkts. diagnostika. 2006; 6: 41–50. [in Russian]
31. Kasius A, Smit JG, Torrance HL et al. Endometrial thickness and pregnancy rates after IVF: a systemstic review and metaanalysis. Hum Reprod Update 2014; 20 (4): 530–41.
32. Wang L, Qiao J, Li R et al. Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF – ET cycles. Reprod Bio lEndocrinol 2010; 8: 122.
33. Germeyer A, von Wolff M, Jauckus J et al. Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures – a pilot study. Reprod Biol Endocrinol 2010; 21 (21): 67.
34. Ng EH, Chan CC, Tang OS et al. Factors affecting endometrial and subendometrial blood flow measured by three – dimensional power Doppler ultrasound during IVF treatment. Hum Repord 2006; 21 (4): 1062–9.
35. Ng EN, Chan CC, Tang OS et al. The role of endometrial blood flow measured by three – dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment. Eur J Obsted Gynecol Repord Biol 2007; 135 (1): 8–16.
36. McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 2006; 59 (8): 801–12.
37. Adegboyega PA, Pei Y, McLarty J. Relationship between eosinofhils and chronic endometritis. Hum Pathol 2010; 41 (1): 33–7.
38. Gilmore H, Fleischhacker D, Hecht JL. Diagnosis of chronic endometritis in biopsies with stromal breakdown. Hum Pathol 2007; 38 (4): 581–4.
39. Giordano G. Value of immunohistochemistry in uterine pathology: common and rare diagnostic dilemmas. Pathol Res Pract 2009; 205 (10): 663–76.
40. Vicetti Miguel RD, Chivukula M, Krishnamurti U et al. Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research. Pathol Res Pract 2011; 207 (11): 680–5.
41. Toth B, Würfel W, Bohlmann MK et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).GeburtshilfeFrauenheilkd 2015; 75 (11): 1117–29.
42. Serov V.N., Kogan E.A., Silant'eva V.S. i dr. Kompleksnoe lechenie khronicheskogo endometrita: kliniko-morfologicheskoe obosnovanie ispol'zovaniia fizioterapii. Akusherstvo i ginekologiia. 2006; 3: 46–50. [in Russian]
43. Serov V.N. Fizicheskie metody predgestatsionnoi podgotovki endometriia: sindromal'no-patogeneticheskii podkhod. Vopr. kurortologii, fizioterapii i lechebnoi fizkul'tury. 2007; 2: 21–6. [in Russian]
44. Gomberg M.A. Vedenie patsientok s vospalitel'nymi zabolevaniiami organov malogo taza: obzor Evropeiskogo rukovodstva Mezhdunarodnogo soiuza po bor'be s infektsiiami, peredavaemymi polovym putem (IUSTI). Ginekology. 2013; 15 (6): 46–9. [in Russian]
45. Tapil'skaia N.I. Primenenie vil'profena u patsientok s besplodiem i privychnym nevynashivaniem beremennosti na etape predgravidarnoi podgotovki. Trudnyi patsient. 2010; 1–2: 27–30. [in Russian]
46. Sukhikh G.T., Shurshalina A.V. Khronicheskii endometrit: rukovodstvo. M.: GEOTAR–Media, 2013. [in Russian]
47. Alimova O.A. Kliniko-morfologicheskaia kharakteristika khronicheskogo endometrita razlichnoi etiologii. Avtoref. dis. … kand. med. nauk. Cheliabinsk, 2011. [in Russian]
48. Borovkova L.V., Kolobova S.O. Vliianie preparata immunovit na sostoianie kletochnogo immuniteta pri nevynashivanii beremennosti infektsionnogo geneza. Meditsinskii al'manakh. 2010; 2: 174–6. [in Russian]
49. Dubnitskaia L.V. Khronicheskii endometrit: vozmozhnosti diagnostiki i lecheniia.Consilium Medicum. 2007; 9 (6): 25–8. [in Russian]
50. Nazarenko T.A., Dubnitskaia L.V. Primenenie preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Akusherstvo i ginekologiia. 2007; 5: 95–8. [in Russian]
51. Nazarenko T.A., Dubnitskaia L.V. Vozmozhnosti primeneniia preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Rus. med. zhurn. 2008; 9: 24–9. [in Russian]
52. Petrovich E.A., Kolesov A.A., Manukhin I.B. Bezopasnost' i effektivnost' preparata «Longidaza» 3000 ME pri lechenii bol'nykh, stradaiushchikh spaechnym protsessom v malom tazu. Immunologiia. 2006; 2: 124–6. [in Russian]
53. Troshina N.A., Dolgushin I.I., Dolgushina V.F. i dr. Mikrobiologicheskaia effektivnost' preparata na osnove gialuronidazy u patsientok s khronicheskim endometritom i miomoi matki. Ginekology. 2015; 17 (6): 42–5. [in Russian]
54. Tsar'kova M.A., Sementsova N.A. Novyi podkhod k kompleksnoi terapii patologii endometriia. Ginekology. 2015; 16 (5): 110–3. [in Russian]
2. Шуршалина А.В. Оптимизация тактики ведения пациенток с воспалительными заболеваниями органов малого таза. Гинекология. 2012; 14 (2). / Shurshalina A.V. Optimizatsiia taktiki vedeniia patsientok s vospalitel'nymi zabolevaniiami organov malogo taza. Ginekology. 2012; 14 (2). [in Russian]
3. Мотовилова Т.М., Качалина Т.С., Аникина Т.А. Альтернативный подход к лечению больных с хроническим неспецифическим эндометритом. РМЖ. Мать и дитя. 2013; 14: 751–6. / Motovilova T.M., Kachalina T.S., Anikina T.A. Al'ternativnyi podkhod k lecheniiu bol'nykh s khronicheskim nespetsificheskim endometritom. RMZh. Mat' i ditia. 2013; 14: 751–6. [in Russian]
4. Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Cur Opin Infect Dis 2008; 21 (1): 65–9.
5. Kumbak B, Erden HF, Tosun S et al. Outcome of assisted reproduction treatmentin patients with endometrial thickness less then 7 mm. Reprod Biomed Online 2009; 18 (1): 79–84.
6. Глухова Е.В., Шаховская И.Н. Микробиологическая характеристика биотопов репродуктивного тракта при эндометрите. Тольяттинский мед. консилиум. 2011; 1–2: 38–44. / Glukhova E.V., Shakhovskaia I.N. Mikrobiologicheskaia kharakteristika biotopov reproduktivnogo trakta pri endometrite. Tol'iattinskii med. konsilium. 2011; 1–2: 38–44. [in Russian]
7. Бухарин О.В., Черкасов С.В., Сгибнев А.В. и др. Характеристика микроэкологических нарушений при эндометрите. Журн. микробиологии, эпидемиологии и иммунобиологии. 2009; 4: 93–6. / Bukharin O.V., Cherkasov S.V., Sgibnev A.V. i dr. Kharakteristika mikroekologicheskikh narushenii pri endometrite. Zhurn. mikrobiologii, epidemiologii i immunobiologii. 2009; 4: 93–6. [in Russian]
8. Шуршалина А.В. Хронический эндометрит: современные подходы к терапии.Consilium Medicum. 2009; 11 (6): 36–8. / Shurshalina A.V. Khronicheskii endometrit: sovremennye podkhody k terapii.Consilium Medicum. 2009; 11 (6): 36–8. [in Russian]
9. Aslim B, Kilic E. Some probiotic properties of vaginal lactobacilli isolated from healthy women. Jpn J Infect Dis 2006; 59 (4): 249–53.
10. Dimitonova SP, Danova ST, Serkedjieva JP et al. Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women. Anaerobe 2007; 13 (5–6): 178–84.
11. Garg KB, Ganguli I, Das R et al. Spectrum of Lactobacillus species present in healthy vagina of Indian women. Indian J Med Res 2009; 129 (6): 652–7.
12. Martin R, Suarez JE. Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol 2010; 76 (2): 400–5.
13. Tamrakar R, Yamada T, Furuta I et al. Association between Lactobacillus species and bacterilvaginosis – related bacteri, and bacterial vaginosis scores in pregnant Japanese women. ВМС Infect Dis 2007; 7: 128.
14. Aagaard K, Petrosino J, Keitel W et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. J FASEB J 2013; 27 (3): 1012–22.
15. Тапильская Н.И., Карпеев С.А., Кузнецова И.В. Хронический эндометрит – субклиническое воспалительное заболевание органов малого таза. Гинекология. 2014; 1: 104–9. / Tapil'skaia N.I., Karpeev S.A., Kuznetsova I.V. Khronicheskii endometrit – subklinicheskoe vospalitel'noe zabolevanie organov malogo taza. Ginekology. 2014; 1: 104–9. [in Russian]
16. Amsler L, Malouli D, De Filippi V. The inflammasome as a target of modulation by DNA viruses. Future Virol Author manuscript; available in PMC Jun 18, 2014.
17. Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J Reprod Immunol 2008; 77: 7–13.
18. Hirata T, Osuga Y, Hamasakia K et al. Expression of toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. J Reprod Immunol 2007; 74 (1–2): 53–60.
19. Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction 2008; 135: 739–49.
20. Le Bouteiller P, Tabiasco J. Killers become builders during pregnancy. Nat Med 2006; 12: 991–2.
21. Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13: 24–8.
22. Tuckerman E, Larid SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 2007; 8: 2208–13.
23. Серебренникова С.Н., Семинский И.Ж. Роль цитокинов в воспалительном процессе (сообщение 2). Сиб. мед. журн. 2008; 83 (8): 5–9. / Serebrennikova S.N., Seminskii I.Zh. Rol' tsitokinov v vospalitel'nom protsesse (soobshchenie 2). Sib. med. zhurn. 2008; 83 (8): 5–9. [in Russian]
24. Smith M, Hagerty KA, Skipper B et al. Chronic endometritis: a combined histopathologic and clinical review of cases from 2002 to 2007. Int J Gynecol Pathol 2010; 29 (1): 44–50.
25. Pitsos M, Skurnick J, Heller D. Association of pathologic diagnoses with clinical findings in chronic endometritis. J Reprod Med 2009; 54 (6): 373–7.
26. Killick SR. Ultrasound and the receptivity of the endometrium. Reprod Biomed Online 2007; 15 (1): 63–7.
27. Caserta L, Labriola D, Torella M et al. The use of transvaginal ultrasound following voluntary interruption f pregnancy to reduce complications due to incomplete curettage. Minerva Ginecol 2008; 60 (1): 7–13.
28. Merce LT, Barco MJ, Bau S et al. Are endometrial parameters by threedimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril 2008; 89 (1): 111–7.
29. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Obstet Gynecol Int 2009; 397079.
30. Озерская И.А., Агеева М.И., Заева В.В. Комплексное ультразвуковое исследование матки у женщин после неудачных попыток экстракорпорального оплодотворения. Ультразвук. функц. диагностика. 2006; 6: 41–50. / Ozerskaia I.A., Ageeva M.I., Zaeva V.V. Kompleksnoe ul'trazvukovoe issledovanie matki u zhenshchin posle neudachnykh popytok ekstrakorporal'nogo oplodotvoreniia. Ul'trazvuk. funkts. diagnostika. 2006; 6: 41–50. [in Russian]
31. Kasius A, Smit JG, Torrance HL et al. Endometrial thickness and pregnancy rates after IVF: a systemstic review and metaanalysis. Hum Reprod Update 2014; 20 (4): 530–41.
32. Wang L, Qiao J, Li R et al. Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF – ET cycles. Reprod Bio lEndocrinol 2010; 8: 122.
33. Germeyer A, von Wolff M, Jauckus J et al. Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures – a pilot study. Reprod Biol Endocrinol 2010; 21 (21): 67.
34. Ng EH, Chan CC, Tang OS et al. Factors affecting endometrial and subendometrial blood flow measured by three – dimensional power Doppler ultrasound during IVF treatment. Hum Repord 2006; 21 (4): 1062–9.
35. Ng EN, Chan CC, Tang OS et al. The role of endometrial blood flow measured by three – dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment. Eur J Obsted Gynecol Repord Biol 2007; 135 (1): 8–16.
36. McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 2006; 59 (8): 801–12.
37. Adegboyega PA, Pei Y, McLarty J. Relationship between eosinofhils and chronic endometritis. Hum Pathol 2010; 41 (1): 33–7.
38. Gilmore H, Fleischhacker D, Hecht JL. Diagnosis of chronic endometritis in biopsies with stromal breakdown. Hum Pathol 2007; 38 (4): 581–4.
39. Giordano G. Value of immunohistochemistry in uterine pathology: common and rare diagnostic dilemmas. Pathol Res Pract 2009; 205 (10): 663–76.
40. Vicetti Miguel RD, Chivukula M, Krishnamurti U et al. Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research. Pathol Res Pract 2011; 207 (11): 680–5.
41. Toth B, Würfel W, Bohlmann MK et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).GeburtshilfeFrauenheilkd 2015; 75 (11): 1117–29.
42. Серов В.Н., Коган Е.А., Силантьева В.С. и др. Комплексное лечение хронического эндометрита: клинико-морфологическое обоснование использования физиотерапии. Акушерство и гинекология. 2006; 3: 46–50. / Serov V.N., Kogan E.A., Silant'eva V.S. i dr. Kompleksnoe lechenie khronicheskogo endometrita: kliniko-morfologicheskoe obosnovanie ispol'zovaniia fizioterapii. Akusherstvo i ginekologiia. 2006; 3: 46–50. [in Russian]
43. Серов В.Н. Физические методы предгестационной подготовки эндометрия: синдромально-патогенетический подход. Вопр. курортологии, физиотерапии и лечебной физкультуры. 2007; 2: 21–6. / Serov V.N. Fizicheskie metody predgestatsionnoi podgotovki endometriia: sindromal'no-patogeneticheskii podkhod. Vopr. kurortologii, fizioterapii i lechebnoi fizkul'tury. 2007; 2: 21–6. [in Russian]
44. Гомберг М.А. Ведение пациенток с воспалительными заболеваниями органов малого таза: обзор Европейского руководства Международного союза по борьбе с инфекциями, передаваемыми половым путем (IUSTI). Гинекология. 2013; 15 (6): 46–9. / Gomberg M.A. Vedenie patsientok s vospalitel'nymi zabolevaniiami organov malogo taza: obzor Evropeiskogo rukovodstva Mezhdunarodnogo soiuza po bor'be s infektsiiami, peredavaemymi polovym putem (IUSTI). Ginekology. 2013; 15 (6): 46–9. [in Russian]
45. Тапильская Н.И. Применение вильпрофена у пациенток с бесплодием и привычным невынашиванием беременности на этапе предгравидарной подготовки. Трудный пациент. 2010; 1–2: 27–30. / Tapil'skaia N.I. Primenenie vil'profena u patsientok s besplodiem i privychnym nevynashivaniem beremennosti na etape predgravidarnoi podgotovki. Trudnyi patsient. 2010; 1–2: 27–30. [in Russian]
46. Сухих Г.Т., Шуршалина А.В. Хронический эндометрит: руководство. М.: ГЭОТАР–Медиа, 2013. / Sukhikh G.T., Shurshalina A.V. Khronicheskii endometrit: rukovodstvo. M.: GEOTAR–Media, 2013. [in Russian]
47. Алимова О.А. Клинико-морфологическая характеристика хронического эндометрита различной этиологии. Автореф. дис. … канд. мед. наук. Челябинск, 2011. / Alimova O.A. Kliniko-morfologicheskaia kharakteristika khronicheskogo endometrita razlichnoi etiologii. Avtoref. dis. … kand. med. nauk. Cheliabinsk, 2011. [in Russian]
48. Боровкова Л.В., Колобова С.О. Влияние препарата иммуновит на состояние клеточного иммунитета при невынашивании беременности инфекционного генеза. Медицинский альманах. 2010; 2: 174–6. / Borovkova L.V., Kolobova S.O. Vliianie preparata immunovit na sostoianie kletochnogo immuniteta pri nevynashivanii beremennosti infektsionnogo geneza. Meditsinskii al'manakh. 2010; 2: 174–6. [in Russian]
49. Дубницкая Л.В. Хронический эндометрит: возможности диагностики и лечения.Consilium Medicum. 2007; 9 (6): 25–8. / Dubnitskaia L.V. Khronicheskii endometrit: vozmozhnosti diagnostiki i lecheniia.Consilium Medicum. 2007; 9 (6): 25–8. [in Russian]
50. Назаренко Т.А., Дубницкая Л.В. Применение препарата Лонгидаза в комплексной терапии патологических изменений эндометрия. Акушерство и гинекология. 2007; 5: 95–8. / Nazarenko T.A., Dubnitskaia L.V. Primenenie preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Akusherstvo i ginekologiia. 2007; 5: 95–8. [in Russian]
51. Назаренко Т.А., Дубницкая Л.В. Возможности применения препарата Лонгидаза в комплексной терапии патологических изменений эндометрия. Рус. мед. журн. 2008; 9: 24–9. / Nazarenko T.A., Dubnitskaia L.V. Vozmozhnosti primeneniia preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Rus. med. zhurn. 2008; 9: 24–9. [in Russian]
52. Петрович Е.А., Колесов А.А., Манухин И.Б. Безопасность и эффективность препарата «Лонгидаза» 3000 МЕ при лечении больных, страдающих спаечным процессом в малом тазу. Иммунология. 2006; 2: 124–6. / Petrovich E.A., Kolesov A.A., Manukhin I.B. Bezopasnost' i effektivnost' preparata «Longidaza» 3000 ME pri lechenii bol'nykh, stradaiushchikh spaechnym protsessom v malom tazu. Immunologiia. 2006; 2: 124–6. [in Russian]
53. Трошина Н.А., Долгушин И.И., Долгушина В.Ф. и др. Микробиологическая эффективность препарата на основе гиалуронидазы у пациенток с хроническим эндометритом и миомой матки. Гинекология. 2015; 17 (6): 42–5. / Troshina N.A., Dolgushin I.I., Dolgushina V.F. i dr. Mikrobiologicheskaia effektivnost' preparata na osnove gialuronidazy u patsientok s khronicheskim endometritom i miomoi matki. Ginekology. 2015; 17 (6): 42–5. [in Russian]
54. Царькова М.А., Семенцова Н.А. Новый подход к комплексной терапии патологии эндометрия. Гинекология. 2015; 16 (5): 110–3. / Tsar'kova M.A., Sementsova N.A. Novyi podkhod k kompleksnoi terapii patologii endometriia. Ginekology. 2015; 16 (5): 110–3. [in Russian]
________________________________________________
2. Shurshalina A.V. Optimizatsiia taktiki vedeniia patsientok s vospalitel'nymi zabolevaniiami organov malogo taza. Ginekology. 2012; 14 (2). [in Russian]
3. Motovilova T.M., Kachalina T.S., Anikina T.A. Al'ternativnyi podkhod k lecheniiu bol'nykh s khronicheskim nespetsificheskim endometritom. RMZh. Mat' i ditia. 2013; 14: 751–6. [in Russian]
4. Haggerty CL. Evidence for a role of Mycoplasma genitalium in pelvic inflammatory disease. Cur Opin Infect Dis 2008; 21 (1): 65–9.
5. Kumbak B, Erden HF, Tosun S et al. Outcome of assisted reproduction treatmentin patients with endometrial thickness less then 7 mm. Reprod Biomed Online 2009; 18 (1): 79–84.
6. Glukhova E.V., Shakhovskaia I.N. Mikrobiologicheskaia kharakteristika biotopov reproduktivnogo trakta pri endometrite. Tol'iattinskii med. konsilium. 2011; 1–2: 38–44. [in Russian]
7. Bukharin O.V., Cherkasov S.V., Sgibnev A.V. i dr. Kharakteristika mikroekologicheskikh narushenii pri endometrite. Zhurn. mikrobiologii, epidemiologii i immunobiologii. 2009; 4: 93–6. [in Russian]
8. Shurshalina A.V. Khronicheskii endometrit: sovremennye podkhody k terapii.Consilium Medicum. 2009; 11 (6): 36–8. [in Russian]
9. Aslim B, Kilic E. Some probiotic properties of vaginal lactobacilli isolated from healthy women. Jpn J Infect Dis 2006; 59 (4): 249–53.
10. Dimitonova SP, Danova ST, Serkedjieva JP et al. Antimicrobial activity and protective properties of vaginal lactobacilli from healthy Bulgarian women. Anaerobe 2007; 13 (5–6): 178–84.
11. Garg KB, Ganguli I, Das R et al. Spectrum of Lactobacillus species present in healthy vagina of Indian women. Indian J Med Res 2009; 129 (6): 652–7.
12. Martin R, Suarez JE. Biosynthesis and degradation of H2O2 by vaginal lactobacilli. Appl Environ Microbiol 2010; 76 (2): 400–5.
13. Tamrakar R, Yamada T, Furuta I et al. Association between Lactobacillus species and bacterilvaginosis – related bacteri, and bacterial vaginosis scores in pregnant Japanese women. ВМС Infect Dis 2007; 7: 128.
14. Aagaard K, Petrosino J, Keitel W et al. The Human Microbiome Project strategy for comprehensive sampling of the human microbiome and why it matters. J FASEB J 2013; 27 (3): 1012–22.
15. Tapil'skaia N.I., Karpeev S.A., Kuznetsova I.V. Khronicheskii endometrit – subklinicheskoe vospalitel'noe zabolevanie organov malogo taza. Ginekology. 2014; 1: 104–9. [in Russian]
16. Amsler L, Malouli D, De Filippi V. The inflammasome as a target of modulation by DNA viruses. Future Virol Author manuscript; available in PMC Jun 18, 2014.
17. Aflatoonian R, Fazeli A. Toll-like receptors in female reproductive tract and their menstrual cycle dependent expression. J Reprod Immunol 2008; 77: 7–13.
18. Hirata T, Osuga Y, Hamasakia K et al. Expression of toll-like receptors 2, 3, 4, and 9 genes in the human endometrium during the menstrual cycle. J Reprod Immunol 2007; 74 (1–2): 53–60.
19. Horne AW, Stock SJ, King AE. Innate immunity and disorders of the female reproductive tract. Reproduction 2008; 135: 739–49.
20. Le Bouteiller P, Tabiasco J. Killers become builders during pregnancy. Nat Med 2006; 12: 991–2.
21. Quenby S, Farquharson R. Uterine natural killer cells, implantation failure and recurrent miscarriage. Reprod Biomed Online 2006; 13: 24–8.
22. Tuckerman E, Larid SM, Prakash A, Li TC. Prognostic value of the measurement of uterine natural killer cells in the endometrium of women with recurrent miscarriage. Hum Reprod 2007; 8: 2208–13.
23. Serebrennikova S.N., Seminskii I.Zh. Rol' tsitokinov v vospalitel'nom protsesse (soobshchenie 2). Sib. med. zhurn. 2008; 83 (8): 5–9. [in Russian]
24. Smith M, Hagerty KA, Skipper B et al. Chronic endometritis: a combined histopathologic and clinical review of cases from 2002 to 2007. Int J Gynecol Pathol 2010; 29 (1): 44–50.
25. Pitsos M, Skurnick J, Heller D. Association of pathologic diagnoses with clinical findings in chronic endometritis. J Reprod Med 2009; 54 (6): 373–7.
26. Killick SR. Ultrasound and the receptivity of the endometrium. Reprod Biomed Online 2007; 15 (1): 63–7.
27. Caserta L, Labriola D, Torella M et al. The use of transvaginal ultrasound following voluntary interruption f pregnancy to reduce complications due to incomplete curettage. Minerva Ginecol 2008; 60 (1): 7–13.
28. Merce LT, Barco MJ, Bau S et al. Are endometrial parameters by threedimensional ultrasound and power Doppler angiography related to in vitro fertilization/embryo transfer outcome? Fertil Steril 2008; 89 (1): 111–7.
29. Senturk LM, Erel CT. Thin endometrium in assisted reproductive technology. Obstet Gynecol Int 2009; 397079.
30. Ozerskaia I.A., Ageeva M.I., Zaeva V.V. Kompleksnoe ul'trazvukovoe issledovanie matki u zhenshchin posle neudachnykh popytok ekstrakorporal'nogo oplodotvoreniia. Ul'trazvuk. funkts. diagnostika. 2006; 6: 41–50. [in Russian]
31. Kasius A, Smit JG, Torrance HL et al. Endometrial thickness and pregnancy rates after IVF: a systemstic review and metaanalysis. Hum Reprod Update 2014; 20 (4): 530–41.
32. Wang L, Qiao J, Li R et al. Role of endometrial blood flow assessment with color Doppler energy in predicting pregnancy outcome of IVF – ET cycles. Reprod Bio lEndocrinol 2010; 8: 122.
33. Germeyer A, von Wolff M, Jauckus J et al. Changes in cell proliferation, but not in vascularisation are characteristic for human endometrium in different reproductive failures – a pilot study. Reprod Biol Endocrinol 2010; 21 (21): 67.
34. Ng EH, Chan CC, Tang OS et al. Factors affecting endometrial and subendometrial blood flow measured by three – dimensional power Doppler ultrasound during IVF treatment. Hum Repord 2006; 21 (4): 1062–9.
35. Ng EN, Chan CC, Tang OS et al. The role of endometrial blood flow measured by three – dimensional power Doppler ultrasound in the prediction of pregnancy during in vitro fertilization treatment. Eur J Obsted Gynecol Repord Biol 2007; 135 (1): 8–16.
36. McCluggage WG. My approach to the interpretation of endometrial biopsies and curettings. J Clin Pathol 2006; 59 (8): 801–12.
37. Adegboyega PA, Pei Y, McLarty J. Relationship between eosinofhils and chronic endometritis. Hum Pathol 2010; 41 (1): 33–7.
38. Gilmore H, Fleischhacker D, Hecht JL. Diagnosis of chronic endometritis in biopsies with stromal breakdown. Hum Pathol 2007; 38 (4): 581–4.
39. Giordano G. Value of immunohistochemistry in uterine pathology: common and rare diagnostic dilemmas. Pathol Res Pract 2009; 205 (10): 663–76.
40. Vicetti Miguel RD, Chivukula M, Krishnamurti U et al. Limitations of the criteria used to diagnose histologic endometritis in epidemiologic pelvic inflammatory disease research. Pathol Res Pract 2011; 207 (11): 680–5.
41. Toth B, Würfel W, Bohlmann MK et al. Recurrent Miscarriage: Diagnostic and Therapeutic Procedures. Guideline of the DGGG (S1-Level, AWMF Registry No. 015/050, December 2013).GeburtshilfeFrauenheilkd 2015; 75 (11): 1117–29.
42. Serov V.N., Kogan E.A., Silant'eva V.S. i dr. Kompleksnoe lechenie khronicheskogo endometrita: kliniko-morfologicheskoe obosnovanie ispol'zovaniia fizioterapii. Akusherstvo i ginekologiia. 2006; 3: 46–50. [in Russian]
43. Serov V.N. Fizicheskie metody predgestatsionnoi podgotovki endometriia: sindromal'no-patogeneticheskii podkhod. Vopr. kurortologii, fizioterapii i lechebnoi fizkul'tury. 2007; 2: 21–6. [in Russian]
44. Gomberg M.A. Vedenie patsientok s vospalitel'nymi zabolevaniiami organov malogo taza: obzor Evropeiskogo rukovodstva Mezhdunarodnogo soiuza po bor'be s infektsiiami, peredavaemymi polovym putem (IUSTI). Ginekology. 2013; 15 (6): 46–9. [in Russian]
45. Tapil'skaia N.I. Primenenie vil'profena u patsientok s besplodiem i privychnym nevynashivaniem beremennosti na etape predgravidarnoi podgotovki. Trudnyi patsient. 2010; 1–2: 27–30. [in Russian]
46. Sukhikh G.T., Shurshalina A.V. Khronicheskii endometrit: rukovodstvo. M.: GEOTAR–Media, 2013. [in Russian]
47. Alimova O.A. Kliniko-morfologicheskaia kharakteristika khronicheskogo endometrita razlichnoi etiologii. Avtoref. dis. … kand. med. nauk. Cheliabinsk, 2011. [in Russian]
48. Borovkova L.V., Kolobova S.O. Vliianie preparata immunovit na sostoianie kletochnogo immuniteta pri nevynashivanii beremennosti infektsionnogo geneza. Meditsinskii al'manakh. 2010; 2: 174–6. [in Russian]
49. Dubnitskaia L.V. Khronicheskii endometrit: vozmozhnosti diagnostiki i lecheniia.Consilium Medicum. 2007; 9 (6): 25–8. [in Russian]
50. Nazarenko T.A., Dubnitskaia L.V. Primenenie preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Akusherstvo i ginekologiia. 2007; 5: 95–8. [in Russian]
51. Nazarenko T.A., Dubnitskaia L.V. Vozmozhnosti primeneniia preparata Longidaza v kompleksnoi terapii patologicheskikh izmenenii endometriia. Rus. med. zhurn. 2008; 9: 24–9. [in Russian]
52. Petrovich E.A., Kolesov A.A., Manukhin I.B. Bezopasnost' i effektivnost' preparata «Longidaza» 3000 ME pri lechenii bol'nykh, stradaiushchikh spaechnym protsessom v malom tazu. Immunologiia. 2006; 2: 124–6. [in Russian]
53. Troshina N.A., Dolgushin I.I., Dolgushina V.F. i dr. Mikrobiologicheskaia effektivnost' preparata na osnove gialuronidazy u patsientok s khronicheskim endometritom i miomoi matki. Ginekology. 2015; 17 (6): 42–5. [in Russian]
54. Tsar'kova M.A., Sementsova N.A. Novyi podkhod k kompleksnoi terapii patologii endometriia. Ginekology. 2015; 16 (5): 110–3. [in Russian]
Авторы
И.В.Кузнецова*, Н.С.Землина, Т.Н.Рашидов
ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
*ms.smith.ivk@gmail.com
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
*ms.smith.ivk@gmail.com
ГБОУ ВПО Первый Московский государственный медицинский университет им. И.М.Сеченова Минздрава России. 119991, Россия, Москва, ул. Трубецкая, д. 8, стр. 2
*ms.smith.ivk@gmail.com
________________________________________________
I.M.Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation. 119991, Russian Federation, Moscow, ul. Trubetskaia, d. 8, str. 2
*ms.smith.ivk@gmail.com
Цель портала OmniDoctor – предоставление профессиональной информации врачам, провизорам и фармацевтам.